Sewage treatment plants (STPs) accumulate
both antibiotic and nonantibiotic
antimicrobial compounds that can select for antibiotic resistant bacteria.
Herein, we aimed to identify the predominant antibacterial compounds
impacting E. coli from Ontario sewage
sludge consisting of thousands of unknown compounds. Among the 10
extracted sludge samples, 6 extracts exerted significant growth inhibition
effects in E. coli. A total of 103
compounds were tentatively detected across the 10 sludge samples by
suspect screening, among which the bacterial enoyl-ACP reductase (FabI)
inhibitor triclocarban was detected at the highest abundance. A hypomorphic
FabI knockdown E. coli strain was highly
susceptible to the sludge extracts, confirming FabI inhibitors as
the primary antibacterial compounds in the sludge. Protein affinity
pulldown identified triclosan as the major ligand binding to a His-tagged
FabI protein from the sludge, despite the higher abundance of triclocarban
in the same samples. Effect-directed analysis was used to determine
the contributions of triclosan to the observed antibacterial potencies.
Antibacterial effects were only detected in F17 and F18 across 20 fractions, which was consistent with the elution
of triclosan and triclocarban in the same two fractions. Further,
potency mass balance analysis confirmed that triclosan explained the
majority (58–113%) of inhibition effects from sludge extracts.
This study highlighted triclosan as the predominant antibacterial
compound in sewage sludge impacting E. coli despite the co-occurrence of numerous other antibiotics and nonantibiotics.